RPG Life Sciences Ltd (RPGLIFE) — Board Meeting | 2 September 2026(3 announcements)

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved API business acquisition via slump sale
🔄 What Changed
Rs. 135 crores consideration, 29 API molecules, 30-day completion target
🔮 What's Next
Transaction completion within 30 days subject to regulatory approvals
💡 Investor Takeaway
This acquisition expands RPG Life Sciences' API manufacturing capabilities without share purchases.

The board approved a business transfer agreement where RPG Active Pharma will acquire Raghava Life Sciences' API and intermediates business via slump sale for up to Rs. 135 crores, including Rs. 19 crores in FY26 revenue and 29 API molecules, to expand its pharmaceutical manufacturing footprint.

2 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved BTA execution for API business acquisition via slump sale
🔄 What Changed
RPG Active Pharma will acquire Raghava's API/intermediates business for up to Rs. 135 crores through asset transfer, not share purchase
🔮 What's Next
Transaction completion expected within 30 days subject to regulatory approvals and closing conditions
💡 Investor Takeaway
This acquisition expands RPG Life Sciences' API capabilities without share dilution or related party complications

On September 2, 2026, RPG Life Sciences approved the execution of a Business Transfer Agreement where its wholly owned subsidiary RPG Active Pharma will acquire the API and intermediates business of Raghava Life Sciences Private Limited via slump sale for up to Rs. 135 crores, including assets and operations but excluding CRAMS. The transaction involves no share purchase and requires regulatory approvals, with completion expected within 30 days subject to conditions.

3 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Investor/analyst call scheduled for September 3, 2026 at 4:00 PM IST
💡 Investor Takeaway
The call will provide insights into the company's strategic direction announced on September 2, 2026.

RPG Life Sciences announced an investor/analyst call on September 3, 2026 at 4:00 PM IST to discuss its strategic announcement made on September 2, 2026, following board approval and a press release. The virtual meeting details will be shared separately, with presentation materials also to be posted on the company website.

About RPG Life Sciences Ltd (RPGLIFE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,456.85 Cr P/E: 37.3 ROE: 19.8% ROCE: 25.8% Div Yield: 0.89%

View full RPGLIFE stock details →

📡 Get AI alerts when RPGLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RPGLIFE — Free

📊 More RPGLIFE filings

See all RPGLIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RPGLIFE files new disclosures

Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RPGLIFE — Free

Free account · 2 AI queries/day